Technology.

Our MOASIS® platform technology

The platform technology MOASIS® enables the construction of novel molecular clusters from small molecules within critical length scales.
These assemblies typically range from 2 to 5 nanometers in size and exhibit surface properties distinct from those of the original molecules.

Features

  • Bottom-up assembly of molecular clusters
    MOASIS® enables the spontaneous self-assembly of drug molecules into stable clusters at the molecular level.
  • Physical mechanism independent of drug chemistry
    Our platform works across a wide range of drug types, regardless of their chemical structures or molecular properties.
  • Seamless integration into existing formulations
    These molecular clusters can be incorporated directly into eye drops, creams, gels, and more—without formulation changes.
  • Significant enhancement of bioavailability (~10x)
    By simultaneously improving solubility and permeability, MOASIS® dramatically increases actual drug absorption and therapeutic outcomes.
  • Enables less invasive delivery routes
    The technology allows for topical or ocular administration instead of injections, enhancing patient compliance and convenience.
  • Scalable and mass-producible (kg scale)
    Production is simple and cost-effective, requiring no expensive equipment, exotic materials, or high-energy processes.
  • Environmentally friendly and safe
    MOASIS® uses no toxic excipients or environmentally harmful substances, making it both safe and sustainable.

MOASIS® is a robust & versatile platform technology.
Our platform holds potential across industries, from pharmaceuticals to cosmetics, functional foods, and advanced materials.